Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

VBI Vaccines Inc

Home Clinical Trial Sponsors and OrganizationsVBI Vaccines Inc

VBI Vaccines Inc

201-310 Hunt Club Rd, Ottawa, Ontario, Canada$1.9M

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

17

6 active

Approvals

1

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

11

64.7%

Phase 3

4

23.5%

Phase 4

1

5.9%

Trial Status Distribution

Active, not recruiting

6

35.3%

Completed

8

47.1%

Terminated

1

5.9%

Withdrawn

2

11.8%

Clinical Trials

Trials sponsored by this organization (17)

PREHEVBRIO Pregnancy Outcomes Registry

Nov 2023120 participants

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a

Oct 2022103 participants

Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a

Mar 2021114 participants

A Double-blind Randomized Controlled Trial to Assess the Lot-to-lot Consistency of Sci-B-Vac™ in Adults

Active, not recruiting

Feb 20183,200 participants

A trial to compare the immune response and safety of 3 doses of Sci-B-Vac™ compared to 3 doses of Engerix-B® in Adults.

Active, not recruiting

Dec 20171,564 participants

Lot-to-lot Consistency of Sci-B-Vac™ in Adults

Dec 20172,838 participants

Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults

Dec 20171,607 participants

Page 1 of 3

Approvals

Approvals by Agency

CANADA

Health Canada

1

Approvals

Recent Approvals

News

No news articles found

On this page

Overview
Clinical Trials17
Approvals1
News

Back to Organizations